Evox Therapeutics plc (NASDAQ:EVOXW – Get Free Report)’s stock price traded down 20% on Tuesday. The company traded as low as $0.24 and last traded at $0.24. 49,535 shares were traded during trading, an increase of 55% from the average session volume of 31,983 shares. The stock had previously closed at $0.30.
Evox Therapeutics Stock Down 6.2%
The firm’s fifty day simple moving average is $0.34 and its 200-day simple moving average is $0.38.
Evox Therapeutics is a biotechnology company based in Oxford, England, focused on developing engineered extracellular vesicles (EVs) as delivery vehicles for medicines. Its platform is designed to use naturally occurring vesicles, including exosomes, to transport therapeutic cargo such as nucleic acids and proteins to specific tissues and cells in the body.
The company’s technology is intended to address challenges associated with delivering complex medicines, particularly to organs and tissues that can be difficult to reach.
Featured Articles
- Five stocks we like better than Evox Therapeutics
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Evox Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evox Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
